Stereotactic Radiotherapy for Brain Metastases
Stereotactic radiotherapy is an innovative treatment enabling to target accurately brain metastases. The aim of this study is to evaluate tumoral response and acute and late toxicity of this treatment.
Metastasis Brain
RADIATION: stereotactic radiotherapy
Evaluation of tumoral response, Evaluation of response using Magnetic resonance imaging (Recist criteria), 4 weeks after treatment|Evaluation of tumoral response, Evaluation of response using Magnetic resonance imaging (Recist criteria), 8 weeks after treatment
Evaluation of toxicity, Evaluation of toxicity using CTCAE v4.0, 1, 3, 6, 9, 12, 15 months after treatment
Stereotactic radiotherapy is an innovative treatment enabling to target accurately brain metastases. The aim of this study is to evaluate tumoral response and acute and late toxicity of this treatment.